R&D spending: $34,723,000
Percentage of revenues: 17.2%
2019 overall revenue ranking: 86
Atricure increased its research and development expenses by 1.7% this year to support product development, regulatory and clinical personnel costs, according to its annual report.
The company is currently developing technologies to treat atrial fibrillation and other related conditions.